secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001213900-25-116128
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences amends equity plan to 1.25M shares, grants 70K restricted shares to CEO and RSUs to other officers
--------------------------------------------------------------------------------

- Board approved Amendment No. 3 to 2023 Equity Incentive Plan, increasing authorized shares from 1M to 1.25M plus annual evergreen.
- CEO Andrew Simpson granted 70,000 restricted shares; COO Mark Hilz 45,000 RSUs; CFO Danielle Watson 15,000 RSUs; each non-employee director 15,000 RSUs.
- Equity awards vest over 2-3 years with continued service; accelerated vesting if Company reaches $250K+ revenue in any future fiscal quarter.
- Amendment and grants conditioned on shareholder approval of Plan Amendment at next annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025116128/0001213900-25-116128-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000121390025116128/ea0267735-8k_heartsci.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-116128

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer